ATLANTA, Feb. 5 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a
biomaterials, medical device and tissue processing company, announced today
that 2008 fourth quarter and year end financial results will be released on
Thursday, February 19, 2009. The Company will hold a teleconference call and
live webcast at 10:00 a.m. Eastern Time, February 19, 2009, to discuss the
results, followed by a question and answer session hosted by Steven G.
Anderson, president and CEO of CryoLife, Inc.
To listen to the live teleconference, please dial 201-689-8261 a few
minutes prior to 10:00 a.m. A replay of the teleconference will be available
February 19 through February 26 and can be accessed by calling (toll free)
877-660-6853 or 201-612-7415. The account number for the replay is 244 and
the conference number is 312509.
The live webcast and replay can be accessed by going to the Investor
Relations section of the CryoLife web site at www.cryolife.com and selecting
the heading Webcasts & Presentations.
About CryoLife, Inc.
Founded in 1984, CryoLife, Inc. is a leader in the processing and
distribution of implantable living human tissues for use in cardiac and
vascular surgeries throughout the U.S. and Canada. The Company recently
received FDA clearance for the CryoValve(R) SG pulmonary human heart valve,
processed using CryoLife's proprietary SynerGraft(R) Technology. The
Company's BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to
sutures and staples for use in adult patients in open surgical repair of large
vessels. BioGlue is also CE marked in the European Community and approved in
Canada and Australia for use in soft tissue repair. CryoLife distributes
Hemostase MPH, a hemostatic agent, in much of the U.S. for use in cardiac and
vascular surgery and in the United Kingdom, Germany, France and Canada for
cardiac, vascular, and general surgery, subject to certain exclusions. The
Company also distributes the CryoLife-O'Brien(R) Stentless Porcine Aortic
Bioprosthesis, which is CE marked for distribution within the European
Community.
For additional information about the company, visit CryoLife's Web site:
http://www.cryolife.com.
SOURCE CryoLife, Inc.
- 02/05/2009
CONTACT: D. Ashley Lee, Executive Vice President,
Chief Financial Officer and Chief Operating Officer,
CryoLife, Inc., +1-770-419-3355;
Katie Brazel,
Fleishman Hillard, +1-404-739-0150
Web Site: http://www.cryolife.com
(CRY)
